Allscripts Healthcare (MDRX) Got Lower Leerink Swann Rating; Martin Marietta Materials Has 0.98 Sentiment

June 19, 2017 - By Ellis Scott

Among 21 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 10 have Buy rating, 1 Sell and 10 Hold. Therefore 48% are positive. Allscripts-Misys Healthcare has $19.0 highest and $12 lowest target. $15.28’s average target is 22.53% above currents $12.47 stock price. Allscripts-Misys Healthcare had 32 analyst reports since August 5, 2015 according to SRatingsIntel. The company was upgraded on Thursday, January 7 by RBC Capital Markets. RBC Capital Markets maintained Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) on Wednesday, August 5 with “Sector Perform” rating. The stock of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has “Underweight” rating given on Tuesday, December 13 by Morgan Stanley. Canaccord Genuity initiated the stock with “Buy” rating in Wednesday, September 16 report. The rating was reinitiated by Jefferies on Friday, October 16 with “Buy”. As per Wednesday, August 5, the company rating was maintained by Topeka Capital Markets. The stock of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has “Buy” rating given on Monday, August 24 by Argus Research. The company was initiated on Tuesday, November 17 by JP Morgan. On Monday, March 27 the stock rating was upgraded by Wells Fargo to “Outperform”. As per Wednesday, March 30, the company rating was upgraded by Morgan Stanley.

Martin Marietta Materials, Inc. is a supplier of aggregates products used for the construction of infrastructure, nonresidential, and residential projects. The company has market cap of $14.48 billion. Aggregates products are also used for railroad ballast and in agricultural, utility and environmental applications. It has a 34.8 P/E ratio. The Company’s Aggregates business operates through three divisions: the Mid-America Group, Southeast Group and West Group.

Ratings analysis reveals 33% of Martin Marietta’s analysts are positive. Out of 3 Wall Street analysts rating Martin Marietta, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. MLM was included in 3 notes of analysts from October 11, 2016. The rating was downgraded by Bank of America to “Neutral” on Wednesday, November 16. The rating was upgraded by SunTrust on Wednesday, October 26 to “Buy”. As per Tuesday, October 11, the company rating was downgraded by Goldman Sachs.

The stock increased 0.40% or $0.91 on June 16, reaching $230.33. About shares traded. Martin Marietta Materials, Inc. (MLM) has risen 23.49% since June 19, 2016 and is uptrending. It has outperformed by 6.79% the S&P500.

Chapter Iv Investors Llc holds 18.13% of its portfolio in Martin Marietta Materials, Inc. for 220,000 shares. Lodge Hill Capital Llc owns 274,900 shares or 7.77% of their US portfolio. Moreover, Foundation Asset Management Lp has 6.49% invested in the company for 96,311 shares. The Australia-based Caledonia (Private) Investments Pty Ltd has invested 6.04% in the stock. Mark Asset Management Corp, a New York-based fund reported 82,127 shares.

Since January 1, 0001, it had 0 insider buys, and 7 selling transactions for $7.14 million activity.

Analysts await Martin Marietta Materials, Inc. (NYSE:MLM) to report earnings on August, 1. They expect $2.50 earnings per share, up 31.58% or $0.60 from last year’s $1.9 per share. MLM’s profit will be $157.17M for 23.03 P/E if the $2.50 EPS becomes a reality. After $0.67 actual earnings per share reported by Martin Marietta Materials, Inc. for the previous quarter, Wall Street now forecasts 273.13% EPS growth.

Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations. The company has market cap of $2.26 billion. The Firm operates through three divisions: Clinical and Financial Solutions, Population Health, and Netsmart. It currently has negative earnings. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Since March 23, 2017, it had 0 insider purchases, and 2 insider sales for $475,850 activity. Poulton Richard J. sold $301,383 worth of stock. On Thursday, March 23 Farley Brian sold $174,467 worth of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) or 15,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: